Home Alexion gets EU approval for drug acquired in Synageva deal
 

Keywords :   


Alexion gets EU approval for drug acquired in Synageva deal

2015-09-02 03:25:24| Biotech - Topix.net

Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease. European health regulators approved Kanuma for patients with lysosomal acid lipase deficiency .

Tags: in deal drug approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
01.11US jobs growth slows as presidential election looms
01.11Heritage Environmental Services Secures Commercial Permit Status for Orange, TX Incinerator
01.11Value for Money tsar linked to string of overspends
01.11Gimme Seaweed Partners with rePurpose Global to Combat Plastic Pollution
01.11Video Catches the Moment a Missouri Battery Recycling Plant Explodes
01.11University of Akron Receives $2M Grant from US DOE for EV Battery Recycling
01.11Iowa Select Farms fights food insecurity year-round
More »